drugset / Trial / NCT07169851

A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer

NCT07169851

Phase 2 Recruiting 204 enrolled Eli Lilly and Company
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to check how well LY35327021 works and how safe it is for controlling nausea and vomiting caused by chemotherapy. Participants who join this study will be in it until all parts are finished, which could take about 2 months.

Timeline

Start
2025-11-28
Primary completion
2026-12
Completion
2027-02

Drugs

EvaluationDrugModalityDoseRoute
Subject LY3537021 Unknown Subcutaneous
Background Cisplatin Other / unclassified Intravenous
Background Cyclophosphamide Other / unclassified Intravenous
Background Dexamethasone Small molecule Oral

Indications